文献速递关节外科骨肿瘤

翻修型远端股骨假体置换的失败与再手术率超过40%

Revision Distal Femoral Replacements Have a More-Than-40% Failure and Reoperation Rate.
PubMed 文献 · J Arthroplasty · 2025-05-12

该回顾性研究纳入2004至2022年间单中心连续接受远端股骨假体置换(DFR)后失败并行翻修型远端股骨假体置换(rDFR)的54例患者,rDFR后平均随访至少2年。结果显示22例(41%)rDFR失败并再手术,5年无再手术生存率为61%,假体周围感染是最常见的rDFR指征(43%)和失败原因(59%),女性与rDFR失败显著相关(P=0.029)。

要点

  • rDFR后41%患者失败并再手术,5年无再手术生存率仅61%。
  • 假体周围感染是rDFR最常见指征(43%)及失败原因(59%)。
  • rDFR后90天再入院率46%、截肢率9%、死亡率11%。

核心结论

  • rDFR的结局较差,再手术率高、术后早期失败、并发症及截肢发生率高。
  • 作者认为在讨论保肢方案时应向患者告知这些结局和风险。

研究设计与样本

  • 回顾性研究,纳入2004年至2022年间单中心连续接受DFR的所有患者,分析其中DFR失败后接受rDFR者。
  • 共54例患者接受rDFR,距初次DFR平均19.7个月,所有患者自rDFR起至少随访2年。

主要发现

  • 54例接受rDFR的患者中,22例(41%)rDFR失败并再手术。
  • rDFR后5年无再手术生存率为61%。
  • rDFR后90天再入院率为46%,截肢率为9%,死亡率为11%。
  • 假体周围感染是rDFR最常见的指征(43%)及rDFR失败最常见的原因(59%)。
  • 女性与rDFR失败显著相关(P=0.029)。

临床怎么用

  • 作者认为,在术前讨论保肢方案时应向患者告知rDFR的高再手术率、早期失败、并发症及截肢风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distal femoral replacement (DFR) is a complex reconstruction option for patients who have substantial bone loss, often following multiple failed revision total knee arthroplasties. However, 5-year survivorship after DFR is only 70 to 85%, and there is a paucity of literature evaluating outcomes following revision distal femoral replacements (rDFRs). Therefore, this study aimed to analyze the survivorship and outcomes of rDFR. METHODS: This retrospective study identified a consecutive cohort of all patients who underwent DFR at a single institution between 2004 and 2022. Among this population, patients who failed DFR and underwent rDFR were analyzed. All patients had a minimum 2-year follow-up from rDFR. There were 54 patients who underwent rDFR at a mean time of 19.7 months after their index DFR. The primary outcome was reoperation after rDFR. Secondary outcomes included the mechanism of failure, complications, readmission, amputation, and mortality. RESULTS: Among the 54 patients who underwent rDFR, 22 patients (41%) failed rDFR and had a reoperation. At the most recent follow-up, patients who had rDFRs had a 46% 90-day readmission rate, 9% amputation rate, and 11% mortality rate. The 5-year reoperation-free survivorship after rDFR was 61%. Periprosthetic joint infection was the most common indication for rDFR (43%) and the most common reason for failure of rDFR (59%). Women were significantly associated with the failure of rDFR (P = 0.029). CONCLUSIONS: The outcomes following rDFR are poor, with high reoperation rates, early postoperative failure, complications, and amputation. These outcomes and risks should be shared with patients when discussing limb salvage options before these operations.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Parikh N, Lam AD, Hohmann AL, et al. Revision Distal Femoral Replacements Have a More-Than-40% Failure and Reoperation Rate. J Arthroplasty. 2025. PMID: 40368077. doi:10.1016/j.arth.2025.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。